Search Within

Sloan Kettering Institute Postdocs

Formats
  1. Journal Article (8036)
  2. Meeting Abstract (3693)
  3. Review (630)
  4. Editorial (262)
  5. Book Section (195)
  6. Conference Paper (161)
  7. Research Letter (139)
  8. Correspondence (68)
  9. Miscellaneous (67)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. GSK Faculty (6363)
  2. Department of Medicine (4809)
  3. Sloan Kettering Institute Faculty (3570)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (3037)
  5. Surgery (2633)
  6. Solid Tumor Oncology Division (2604)

More Groups

People
  1. Britta Weigelt (376)
  2. Jorge Reis-Filho (328)
  3. Mithat Gonen (318)
  4. Marc Ladanyi (309)
  5. Michael Berger (288)
  6. Joseph Deasy (285)

More People

Years
  1. 2026 (1)
  2. 2025 (697)
  3. 2024 (1080)
  4. 2023 (1152)
  5. 2022 (1366)
  6. 2021 (1179)

More Years

Publications
  1. Blood (680)
  2. Cancer Research (543)
  3. Journal of Clinical Oncology (431)
  4. Journal of Nuclear Medicine (271)
  5. Annals of Surgical Oncology (264)
  6. Clinical Cancer Research (249)

More Publications

Publishers
  1. Nature Publishing Group (1349)
  2. Elsevier Inc. (1106)
  3. American Association for Cancer Research (1058)
  4. Springer (840)
  5. American Society of Hematology (740)
  6. Cell Press (740)

More Publishers

Results (13287)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ASXL2 is a novel mediator of RUNX1-ETO transcriptional function and collaborates with RUNX1-ETO to promote leukemogenesis
    Meeting Abstract

    Micol, J. B.; Duployez, N.; Pastore, A.; Williams, R.; Kim, E.; Lee, S.; Durham, B.; Chung, Y. R.; Cho, H. N.; Preudhomme, C.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • MSI2 is required for maintaining the activated myelodysplastic syndrome stem cell
    Meeting Abstract

    Ho, T. C.; Taggart, J.; Amin, E.; Xu, H. M.; Barlowe, T.; Perez, A. R.; Tivnan, P.; Okabe, R.; Lengner, C.; Verma, A.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Desuppressed expressions of MiR-29 targets disturb the leukemeugenesis of MLL-AF9
    Meeting Abstract

    Hu, W. H.; Park, C. Y.
    Blood (2015)

    Fulltext@MSK | Save
  • Lysine-specific histone demethylase, LSD1, (KDM1A) as a novel therapeutic target in myeloproliferative neoplasms
    Meeting Abstract

    Kleppe, M.; Shank, K.; Papalexi, E.; Riehnhoff, H.; Levine, R. L.
    Blood (2015)

    Fulltext@MSK | Save
  • Wilms' tumor 1 protein is highly expressed on malignant plasma cells and provides a novel target for immunotherapeutic approaches
    Meeting Abstract

    Koehne, G.; Kosuri, S.; Doubrovina, E.; Dao, T.; Scott, A.; Jungbluth, A. A.; O'Reilly, R. J.
    Blood (2015)

    Fulltext@MSK | Save
  • BAP1 loss results in EZH2-dependent transformation in myelodysplastic syndromes
    Meeting Abstract

    LaFave, L. M.; Beguelin, W.; Koche, R.; Teater, M.; Papalexi, E.; Spitzer, B.; Knutson, S.; Campbell, J.; Keilhack, H.; Thomas, P. M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Hairy cell leukemia variant has similar survival to classical disease despite poorer responses to initial therapy: A 30-year experience from Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Getta, B.; Woo, K. M.; Devlin, S.; Park, J. H.; Abdel-Wahab, O.; Tallman, M. S.
    Blood (2015)

    Fulltext@MSK | Save
  • Prmt5 negatively regulates erythropoiesis by multiple mechanisms, including controlling DNA methyltransferase 3A protein levels
    Meeting Abstract

    Hamard, P. J.; Luciani, L.; Liu, F.; Cheng, G. Y.; Hatlen, M. A.; Guryanova, O. A.; Zhao, X. Y.; Levine, R. L.; Nimer, S. D.
    Blood (2015)

    Fulltext@MSK | Save
  • Diverse and targetable kinase alterations drive histiocytic neoplasms
    Meeting Abstract

    Durham, B. H.; Diamond, E. L.; Haroche, J.; Yao, Z.; Ma, J.; Parikh, S. A.; Choi, J.; Kim, E.; Cohen-Aubart, F.; Lee, S. C. W.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Disruptive ARID1A mutations in follicular lymphoma impair DNA repair efficiency and are associated with favorable outcome in patients receiving first-line immunochemotherapy
    Meeting Abstract

    Bararia, D.; Heide, M.; Welner, R. S.; Romashova, T.; Pastore, A.; Mathur, R.; Gascoyne, R. D.; Kridel, R.; Willson, B. G.; Roberts, C. W. M.; more...
    Blood (2015)

    Fulltext@MSK | Save